Syndax Pharmaceuticals Reports First Quarter 2017 Financial Results and Provides Clinical and Business Update

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 6/23/2026

1. SPCX
2. NVDA
3. ACN
4. USO
5. DFTX
6. GOOGL
7. APGE
8. HOOD
9. MU
10. IBM

Go back to Syndax Pharmaceuticals Reports First Quarter 2017 Financial Results and Provides Clinical and Business Update

Syndax Pharmaceuticals (SNDX) Misses Q1 EPS by 3c

May 8, 2017 4:07 PM EDT

Syndax Pharmaceuticals (NASDAQ: SNDX) reported Q1 EPS of ($0.71), $0.03 worse than the analyst estimate of ($0.68). Revenue for the quarter came in at $305 thousand versus the consensus estimate of $250 thousand.

As of March 31, 2017, Syndax had cash, cash equivalents and short-term investments of $92.8 million and 18,244,917 shares issued and... More